Inhibitors of the small membrane (M) protein viroporin prevent Zika virus infection
- University of Leeds, United Kingdom
- MRC University of Glasgow Centre for Virus Research, United Kingdom
Abstract
Flaviviruses, including Zika virus (ZIKV), are a significant global health concern, yet no licensed antivirals exist to treat disease. The small Membrane (M) protein plays well-defined roles during viral egress and remains within virion membranes following release and maturation. However, it is unclear whether M plays a functional role in this setting. Here, we show that M forms oligomeric membrane-permeabilising channels in vitro, with increased activity at acidic pH and sensitivity to the prototypic channel-blocker, rimantadine. Accordingly, rimantadine blocked an early stage of ZIKV cell culture infection. Structure-based channel models, comprising hexameric arrangements of two trans-membrane domain protomers were shown to comprise more stable assemblages than other oligomers using molecular dynamics (MD) simulations. Models contained a predicted lumenal rimantadine binding site, as well as a second druggable target region on the membrane-exposed periphery. In silico screening enriched for repurposed drugs/compounds predicted to bind to either one site or the other. Hits displayed superior potency in vitro and in cell culture compared with rimantadine, with efficacy demonstrably linked to virion-resident channels. Finally, rimantadine effectively blocked ZIKV viraemia in preclinical models, supporting that M constitutes a physiologically relevant target. This could be explored by repurposing rimantadine, or development of new M-targeted-therapies.
Data availability
All data generated or analysed during this study are included in the manuscript and supporting files; access to MD data and molecular models may be requested and, if accepted, accessed via MTA. Raw simulation data can be accessed via the Leeds Data Repository (https://archive.researchdata.leeds.ac.uk/) at the following DOI: https://doi.org/10.5518/1505
-
ZIKV M protein simulation dataLeeds Data Repository, 974.
Article and author information
Author details
Daniella A Lefteri
Funding
Medical Research Council (G0700124)
- Matthew J Bentham
- Stephen Griffin
University of Leeds (LIMR Studentship)
- Emma Brown
- Richard Foster
- Clive S McKimmie
- Antreas C Kalli
- Stephen Griffin
Medical Research Council (MC_UU_12014/8)
- Claire Donald
- Alain Kohl
Medical Research Council (MR/N017552/1)
- Claire Donald
- Alain Kohl
University of Leeds (LIMR Studentship)
- Daniella A Lefteri
- Clive S McKimmie
- Stephen Griffin
Medical Research Council (MR/T016205/1)
- Amy Moran
- Stephen Griffin
UK Research and Innovation (Impact Acceleration Account ( IAA))
- Gemma Swinscoe
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: Procedures were carried out in accordance with the United Kingdom Home Office regulations under the authority of the appropriate project and personal license (awarded to CSM, and CSM/DL respectively).
Copyright
© 2024, Brown et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 653
- views
-
- 144
- downloads
-
- 3
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Inhibitors of the small membrane (M) protein viroporin prevent Zika virus infection
eLife 13:e68404.
https://doi.org/10.7554/eLife.68404
